TuHURA Biosciences, Inc. HURA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0— | $0— | $0— | $0— | $0— | ||
| $21.18M+47.8% | $20.53M+54.0% | $18.45M+94.9% | $16.43M+96.0% | $14.33M+30.4% | ||
| —— | —— | $10M+186% | $9.03M+136% | $4.87M+26.1% | ||
| $32.31M+61.1% | $31.8M+80.2% | $29.32M+126% | $26.32M+116% | $20.06M-35.4% | ||
| —— | —— | —— | —— | —— | ||
| $1.38M-47.1% | $1.74M-25.4% | $4.19M+374% | $4.62M+393% | $2.62M+1,330% | ||
| -$30.92M-31.6% | -$30.05M-38.6% | -$29.29M-75.3% | -$27.76M-97.0% | -$23.5M+23.9% | ||
| -$0.61— | -$0.63— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.